Jaroslaw K.
- Country
- Poland
- Department
- NA
Research Overview
Data & Insights
Has run more than one trial at 0 of 60 partner sites.
Specializations
Oncology Research
This investigator specializes in non-small cell lung cancer (NSCLC) with a particular focus on patients with RET fusion-positive mutations. Their research encompasses therapeutic approaches for early-stage lung cancer treatment.
- Targeted Therapy Development
- Post-Surgical Treatment Strategies
- Stage II-IIIA NSCLC Management
The investigator's work centers on evaluating novel therapeutic approaches for patients with specific genetic alterations in lung cancer.
Precision Medicine
The investigator focuses on biomarker-driven treatment approaches, specifically investigating therapies targeting RET fusion mutations in lung cancer patients.
- Molecular Profiling
- Personalized Treatment Strategies
- Genetic Mutation Analysis
Their research contributes to advancing personalized medicine approaches in oncology treatment.
Clinical Outcomes
Research interests include investigating event-free survival in early-stage lung cancer patients. The investigator evaluates therapeutic interventions in the adjuvant setting.
- Survival Analysis
- Treatment Efficacy Assessment
- Long-term Patient Outcomes
The focus extends to understanding treatment effectiveness in early-stage disease management.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.